News from abide therapeutics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

May 10, 2016, 08:00 ET Abide Therapeutics Announces First Subject Dosed In PET Occupancy Study with [18F]ABX-1488, A Proprietary Human Monoacylglycerol Lipase (MGLL)-Specific PET Ligand

Abide Therapeutics, a developer of innovative pharmaceuticals, announced today initiation of enrollment and dosing in a Phase 1 PET occupancy study...


Jan 19, 2016, 08:00 ET Abide Therapeutics Appoints Richard N. Kender to Board of Directors

 Abide Therapeutics announced today the appointment of Richard N. Kender to its Board of Directors. Kender is a consultant to biotechnology...


Jan 06, 2016, 08:00 ET Abide Therapeutics Appoints Dr. Chan Beals As Chief Medical Officer

Abide Therapeutics announced today the appointment of Chan Beals, M.D., Ph.D., to the position of Chief Medical Officer. Dr. Beals has more than 15...


Sep 08, 2015, 08:00 ET Abide Therapeutics Appoints Donald Hertzog as Vice President, Early Lead Identification

 Abide Therapeutics announced today the appointment of Donald Hertzog, Ph.D., as Vice President, Early Lead Identification....


Feb 28, 2014, 08:00 ET Abide Therapeutics Announces Strategic Drug Discovery Collaboration with Celgene Corporation to Advance Treatment Paradigm for Patients with Immune Disorders

 Abide Therapeutics today announced it has entered into a strategic collaboration with Celgene Corporation to discover and develop new drugs...


Oct 29, 2013, 08:00 ET Abide Therapeutics Appoints Dr. Gary O'Neill as Vice President of Biology

 Abide Therapeutics announces today that Gary O'Neill, Ph.D., has joined Abide Therapeutics as vice president of biology and member of the...